Sunshine Biopharma Inc. (SBFMW)
0.20
0.03 (16.96%)
At close: Jan 17, 2025, 3:56 PM
0.20
0.00%
After-hours Jan 17, 2025, 03:57 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 |
| Net Income | -4.51M | -26.74M | -12.44M | -2.78M | -1.66M | -2.16M | -1.04M | -3.50M | -1.65M | -1.93M | -2.49M | -707.95K | -556.20K | -537.38K | -25.02K | -31.11K | -13.12K |
| Depreciation & Amortization | 149.15K | 25.16K | 12.74K | 14.07K | 13.77K | 49.36K | 6.63K | 60.73K | 4.25K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Stock-Based Compensation | n/a | n/a | 918.00K | 50.00K | 261.69K | 676.10K | 427.40K | 702.30K | 116.50K | 1.26M | 1.25M | 272.88K | 267.38K | 237.20K | n/a | n/a | n/a |
| Other Working Capital | -94.39K | 276.87K | -2.88K | 1.72K | 4.11K | 8.40K | -8.46K | -72.03K | -16.57K | 13.47K | 3.52K | 44.86K | -512 | -45.23K | 2.53K | -141 | n/a |
| Other Non-Cash Items | n/a | 18.32M | 10.70M | 2.16M | 1.18M | 1.54M | 507.35K | 3.21M | 704.53K | 113.18K | 654.04K | 272.88K | -556.20K | 237.20K | 7.50K | n/a | 8.50K |
| Deferred Income Tax | n/a | 3.63K | -918.00K | -50.00K | -261.69K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -4.42M | 3.15M | -108.80K | -42.64K | -30.92K | 54.58K | -17.26K | -90.99K | 75.74K | 24.43K | 26.74K | 42.02K | -8.48K | -48.14K | 7.29K | 3.57K | 1.50K |
| Operating Cash Flow | -8.78M | -5.25M | -1.83M | -657.30K | -495.80K | -512.81K | -543.52K | -314.18K | -867.64K | -538.60K | -564.40K | -393.05K | -297.30K | -348.32K | -10.22K | -27.53K | -3.12K |
| Capital Expenditures | -788.10K | -305.00K | n/a | -1.19K | -860 | -18.85K | -3.72K | -3.44K | -623.60K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | -14.35M | n/a | n/a | n/a | 4.94K | -80.29K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -573.90K | 33.38K | n/a | n/a | -14.42K | n/a | n/a | n/a | -618.81K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Investing Cash Flow | -656.15K | -14.62M | n/a | -1.19K | -15.28K | -13.91K | -84.01K | -3.44K | -623.60K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Debt Repayment | -125.99K | -1.93M | 2.90M | 1.61M | 416.46K | 470.95K | 570.57K | 198.18K | 1.16M | 497.44K | 463.00K | 62.50K | n/a | n/a | 6.50K | 12.50K | n/a |
| Common Stock Repurchased | -541.14K | -99.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 7.00K | 11.13M | n/a | n/a | 25.80K | 56.69K | 100.14K | 126.44K | n/a | 153.33K | n/a | n/a | n/a | n/a | n/a | 4.50K | -23.98K |
| Financial Cash Flow | 3.43M | 39.47M | 2.90M | 1.61M | 442.25K | 527.64K | 670.71K | 324.62K | 1.40M | 650.78K | 463.00K | 465.00K | 195.60K | 398.60K | 6.50K | 17.00K | 18.02K |
| Net Cash Flow | -5.53M | 19.78M | 1.06M | 949.39K | -74.72K | 7.68K | 50.08K | 6.66K | -92.63K | 112.18K | -101.40K | 71.95K | -101.70K | 50.27K | -3.73K | -10.53K | 14.89K |
| Free Cash Flow | -9.56M | -5.55M | -1.83M | -658.49K | -496.66K | -531.66K | -547.24K | -317.62K | -1.49M | -538.60K | -564.40K | -393.05K | -297.30K | -348.32K | -10.22K | -27.53K | -3.12K |